Authors
Latest:
Fernando Dangond, MD, MBA: Phase 2 Data on Evobrutinib in MSHead of Global Clinical Development in Neurology at EMD Serono discussed the findings of a phase 2 assessment of the company’s investigational BTK inhibitor evobrutinib in multiple sclerosis.
Latest:
Addressing the Neurologist Shortage Through Career Opportunities and Supporting Early Investigators: Claire Henchcliffe, MD, DPhil, FANA; Ali Ezzati, MDA pair of neurologists from the University of California, Irvine, detailed some of the training and career focuses of large federal agencies in effort to address the shortage of neurologists. [WATCH TIME: 4 minutes]
Latest:
Antiplatelets Versus Anticoagulation For the Treatment of Cervical Artery Dissection: Shadi Yaghi, MDThe associate professor of neurology at Brown University talked about findings from an observational study investigating treatment options antiplatelets and anticoagulation for cervical artery dissection. [WATCH TIME: 8 minutes]
Latest:
Andrew Satlin, MD: Lumateperone for Agitation in Patients with Dementia, Alzheimer DiseaseData from an interim analysis of the lumateperone large phase III clinical trial for agitation in subjects with dementia is expected by the end of 2018.
Latest:
Kelvin Tsoi, PhD: Combination Therapy, Monotherapy in Alzheimer DiseaseAfter identifying and reviewing 76 randomized trials, combination therapy with memantine and AChEIs is confirmed to have no additional benefits over monotherapy.
Latest:
Exploring the Burden of Cerebrovascular Disease in VirginiaLocated in the “Stroke Belt” of the US, Virginia presents a unique perspective on the interplay of social, ethnic, and cultural implications on population health.
Latest:
David Wolk, MD: Utilizing MRI in Alzheimer DiseaseThe co-director of the University of Pennsylvania Memory Center will share additional insights on Alzheimer disease at the upcoming International Congress on the Future of Neurology, taking place September 27-28, 2019 in New York City.
Latest:
The Future Outlook for Alzheimer’s DiseaseSharon Cohen, MD, and Marwan Sabbagh, MD, share their final thoughts on Alzheimer's disease and offer advice on strategies to reduce the risk of developing AD and slow the progression of the disease for those already affected.
Latest:
Jenny van der Steen, PhD: Utilizing Palliative Care in DementiaThe associate professor at Leiden University Medical Center detailed how palliative care can be used more effectively in patients with dementia.
Latest:
Therapies to Preserve Function and Quality of LifeAn expert discusses how treatment for the 13-year-old patient should optimize standard care with cardiac and pulmonary monitoring while considering newer therapies like givinostat and casimersen, plus exploring research trials for gene transfer and muscle health approaches.
Latest:
Refining Our Strategy in Alzheimer Disease: Amyloid, Tau, and BeyondReisa Sperling, MD sat down with NeurologyLive to discuss why she thinks investigational drugs for Alzheimer disease are failing, and what she feels are the most promising treatment avenues.
Latest:
Howard Weiner, MD: Entering a New Era in MSThe director of the Partners Multiple Sclerosis Center at Brigham and Women's Hospital spoke about the future of multiple sclerosis.
Latest:
Complexities With SMN2 Copies in Spinal Muscular Atrophy: Basil Darras, MDThe associate neurologist-in-chief at Boston Children’s Hospital discussed the 4-copy conundrum and whether treatment decisions differ based on SMN2 copies for patients with spinal muscular atrophy. [WATCH TIME: 2 minutes]
Latest:
The Role of Aging in Multiple Sclerosis CareExperts discussed how aging impacts multiple sclerosis management, treatment decisions, and overall patient health. [WATCH TIME: 5 minutes]
Latest:
Kate Davis, MD, MSTR: Increasing Treatment Options for Epilepsy PatientsThe epileptologist at the University of Pennsylvania spoke about the multiple options for patients with epilepsy and the need for a better understanding of choosing from the options.
Latest:
FDA Approves Riptide Aspiration System for Acute Ischemic StrokeThe FDA has approved the Riptide Aspiration System for thrombus retrieval via the Arc Catheter for revascularization in patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease.
Latest:
Marking a New Era in Patient Care With Advancements in Disease-Modifying Alzheimer Treatments: Alireza Atri, MD, PhDThe director of the Banner Sun Health Research Institute talked about how the newly approved Alzheimer treatments have shown promise in slowing clinical decline, signaling a foundational shift toward disease-modifying therapies that target core biological processes. [WATCH TIME: 5 minutes]
Latest:
Pediatric Sleep Disorders: Assessment and TreatmentThe long-term consequences of untreated—and prevalent—sleep disorders in children and adolescents point to a need for a focus on this field of care.
Latest:
David Langer, MD: Answering the Call for COVID-19The chair of neurosurgery at Lenox Hill Hospital in Manhattan recently joined the ranks of health care providers who are caring for COVID-19 patients at the temporary hospital set up in the Javits Center.
Latest:
Tessa Blanken, MSc: Identification of Robust, Clinically Relevant Insomnia SubtypesThe identification of the subtypes allows future studies to target homogeneous subtype samples, resolve inconsistencies, personalize treatment and utilize preventive interventions.
Latest:
Marc Nuwer Explores the 2019 CPT Codes for EpilepsyThe professor and vice chair of the neurology department at UCLA discussed the new VNS, RNS and DBS CPT codes for 2019.
Latest:
Joshua Cohen, MD: Fremanezumab's Impact on Quality of Life and ComorbiditiesThe Global Medical Lead for Migraine and Headache at Teva Pharmaceuticals provided insight into how fremanezumab has helped to improve these facets of the condition.
